BRPI1015311A2 - método, dispositivo e kit para determinar a quantidade de polipetídeo de neurotoxina processada e processada ativa em uma solução contendo polipeptídeo de neurotoxina processada e parcialmente processada e/ou não processada - Google Patents

método, dispositivo e kit para determinar a quantidade de polipetídeo de neurotoxina processada e processada ativa em uma solução contendo polipeptídeo de neurotoxina processada e parcialmente processada e/ou não processada

Info

Publication number
BRPI1015311A2
BRPI1015311A2 BRPI1015311A BRPI1015311A BRPI1015311A2 BR PI1015311 A2 BRPI1015311 A2 BR PI1015311A2 BR PI1015311 A BRPI1015311 A BR PI1015311A BR PI1015311 A BRPI1015311 A BR PI1015311A BR PI1015311 A2 BRPI1015311 A2 BR PI1015311A2
Authority
BR
Brazil
Prior art keywords
processed
neurotoxin polypeptide
kit
determining
solution containing
Prior art date
Application number
BRPI1015311A
Other languages
English (en)
Inventor
Josef Friedrich
Michael Pfeil
Original Assignee
Merz Pharma Gmbh & Co Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz Pharma Gmbh & Co Kgaa filed Critical Merz Pharma Gmbh & Co Kgaa
Publication of BRPI1015311A2 publication Critical patent/BRPI1015311A2/pt
Publication of BRPI1015311B1 publication Critical patent/BRPI1015311B1/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306Solid-phase reaction mechanisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/33Assays involving biological materials from specific organisms or of a specific nature from bacteria from Clostridium (G)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
BRPI1015311-0A 2009-04-27 2010-04-23 Método para determinar a quantidade de polipeptídeo de neurotoxina processada em uma solução, dispositivo para determinação da quantidade de polipeptídeo de neurotoxina processada contida em uma solução e kit adaptado BRPI1015311B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21465009P 2009-04-27 2009-04-27
EP09158788 2009-04-27
EP09158788.1 2009-04-27
US61/214,650 2009-04-27
PCT/EP2010/055432 WO2010124998A1 (en) 2009-04-27 2010-04-23 Means and methods for the determination of the amount of neurotoxin polypeptide and of its catalytic and proteolytic activities

Publications (2)

Publication Number Publication Date
BRPI1015311A2 true BRPI1015311A2 (pt) 2016-04-19
BRPI1015311B1 BRPI1015311B1 (pt) 2024-01-09

Family

ID=41066304

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1015311-0A BRPI1015311B1 (pt) 2009-04-27 2010-04-23 Método para determinar a quantidade de polipeptídeo de neurotoxina processada em uma solução, dispositivo para determinação da quantidade de polipeptídeo de neurotoxina processada contida em uma solução e kit adaptado

Country Status (15)

Country Link
US (2) US8663942B2 (pt)
EP (1) EP2425251B1 (pt)
JP (1) JP5689113B2 (pt)
KR (1) KR101818777B1 (pt)
CN (1) CN102414564B (pt)
AU (1) AU2010243692B2 (pt)
BR (1) BRPI1015311B1 (pt)
CA (1) CA2757637C (pt)
ES (1) ES2647243T3 (pt)
HK (1) HK1169171A1 (pt)
IL (1) IL215441A (pt)
MX (1) MX2011011045A (pt)
PT (1) PT2425251T (pt)
RU (1) RU2545783C9 (pt)
WO (1) WO2010124998A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2544060T3 (es) * 2010-08-11 2015-08-27 Merz Pharma Gmbh & Co. Kgaa Fabricación selectiva de polipéptidos de neurotoxina recombinantes
JP6156954B2 (ja) 2012-11-21 2017-07-05 イプセン バイオイノベーション リミテッド タンパク分解性にプロセシングされたポリペプチドの製造方法
JP6608357B2 (ja) * 2013-06-28 2019-11-20 メルツ ファルマ ゲーエムベーハー ウント コンパニー カーゲーアーアー 細胞において神経毒ポリペプチドの生物活性を決定する手段及び方法
US10634683B2 (en) 2014-11-21 2020-04-28 Merz Pharma Gmbh & Co. Kgaa Methods for the determination of the biological activities of neurotoxin polypeptides
RU2694964C2 (ru) * 2017-12-19 2019-07-19 ФЕДЕРАЛЬНОЕ АГЕНТСТВО ПО ТЕХНИЧЕСКОМУ РЕГУЛИРОВАНИЮ И МЕТРОЛОГИИ (Росстандарт) Способ измерений каталитической активности (каталитической концентрации) ферментов с использованием методов масс-спектрометрии и спектрофотометрии с предварительной идентификацией целевого аналита и определением чистоты веществ
JP7394767B2 (ja) 2018-01-12 2023-12-08 ジェンザイム・コーポレーション ポリペプチドの定量化方法
WO2020206375A1 (en) * 2019-04-03 2020-10-08 Technical University Of Denmark Neurotrophic factor protein conjugates and related embodiments

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208479A (en) * 1977-07-14 1980-06-17 Syva Company Label modified immunoassays
DE69033457T2 (de) * 1989-08-16 2000-09-14 Chiron Corp Prohormonspaltungsplatzblockierungsantikörper
GB9411138D0 (en) * 1994-06-03 1994-07-27 Microbiological Res Authority Toxin assay
DE60032367T3 (de) * 1999-08-25 2011-03-10 Allergan, Inc., Irvine Aktivierbare rekombinante neurotoxine
US6678651B2 (en) 2000-09-15 2004-01-13 Mindspeed Technologies, Inc. Short-term enhancement in CELP speech coding
US20060063221A1 (en) * 2004-09-21 2006-03-23 Williams Dudley J Lanthanide-based substrates and methods for determining clostridial toxin activity
US7332567B2 (en) * 2001-08-28 2008-02-19 Allergan, Inc. Fret protease assays for clostridial toxins
JP5178009B2 (ja) * 2003-12-19 2013-04-10 ウィスコンシン アルムニ リサーチ ファンデイション ボツリヌス神経毒素検出のための方法および複合体
FR2869908B1 (fr) * 2004-05-05 2006-07-28 Pharmaleads Substrat peptidique reconnu par la toxine botulique de type a, bont/a et son utilisation pour detecter et/ou doser ladite toxine ou des inhibiteurs de son activite
KR20100020972A (ko) * 2007-06-01 2010-02-23 메르츠 파마 게엠베하 운트 코. 카가아 보툴리늄 톡신의 신경독 성분에 기초한 온도-안정한 근육 이완제를 제공하는 방법
WO2008157374A1 (en) * 2007-06-13 2008-12-24 The United States Of America, As Represented By The Secretrary Of Agriculture High-affinity monoclonal antibodies for botulinum toxin type a
EP2178905B1 (en) * 2007-07-26 2013-11-06 Allergan, Inc. Methods of activiting clostridial toxins
CN101386648B (zh) * 2008-09-25 2012-05-30 中国人民解放军军事医学科学院微生物流行病研究所 抗b型肉毒神经毒素中和性单克隆抗体、其制备方法及用途
MX340772B (es) * 2009-02-19 2016-07-26 Merz Pharma Gmbh & Co Kgaa Medios y metodos para fabricar neurotoxina altamente pura.

Also Published As

Publication number Publication date
CN102414564A (zh) 2012-04-11
RU2545783C9 (ru) 2016-02-27
CA2757637C (en) 2017-10-24
AU2010243692A1 (en) 2011-10-27
IL215441A0 (en) 2011-12-29
ES2647243T3 (es) 2017-12-20
AU2010243692B2 (en) 2015-03-05
HK1169171A1 (en) 2013-01-18
RU2011147994A (ru) 2013-06-10
IL215441A (en) 2015-04-30
US20120142024A1 (en) 2012-06-07
MX2011011045A (es) 2011-11-04
EP2425251B1 (en) 2017-10-25
US8663942B2 (en) 2014-03-04
PT2425251T (pt) 2017-11-27
KR20120005041A (ko) 2012-01-13
CN102414564B (zh) 2015-01-21
JP2012525563A (ja) 2012-10-22
CA2757637A1 (en) 2010-11-04
KR101818777B1 (ko) 2018-01-15
US20140134643A1 (en) 2014-05-15
BRPI1015311B1 (pt) 2024-01-09
EP2425251A1 (en) 2012-03-07
JP5689113B2 (ja) 2015-03-25
RU2545783C2 (ru) 2015-04-10
WO2010124998A1 (en) 2010-11-04

Similar Documents

Publication Publication Date Title
BR112012029897A2 (pt) método para reduzir a quantidade de uma serina protease ou um zimogênio de serina protease em uma composição, método para preparar uma composição, composição de proteína derivada de plasma, e, método para tratamento de uma doença
HRP20181989T1 (hr) Sredstva za i postupci određivanja biološke aktivnosti neurotoksičnih polipeptida u stanicama
BRPI1015311A2 (pt) método, dispositivo e kit para determinar a quantidade de polipetídeo de neurotoxina processada e processada ativa em uma solução contendo polipeptídeo de neurotoxina processada e parcialmente processada e/ou não processada
BR112012002140A2 (pt) métodos para purificar recombinante a tipo desintegrina e metalopeptidase com proteína trombospondina e para inativar contaminantes de vírus em uma amostra de proteína,e, composição.
BRPI1011886A2 (pt) solução contendo ácido hiplocloroso e métodos do uso do mesmo.
BRPI1015026A2 (pt) método e aparelho para facilitar os procedimentos de medição em operação de multiportadora.
BRPI1007477A2 (pt) método, e, composição de tratamento de poço
EE200900072A (et) Territooriumi ja selle perimeetri jälgimise süsteem ja meetod
BRPI0914824A2 (pt) produção de proteína melhorada e armazenagem em plantas
BR112014010162A8 (pt) uso de composição, método para melhorar o reconhecimento e/ou tratar ou prevenir função de reconhecimento prejudicada em um indivíduo, e composição
BR112012002137A2 (pt) método para um polipeptídeo e/ou vírus de interesse em uma cultura de célula contínua,e, composição
BRPI1006145A2 (pt) "composição e método para tratamento de diabetes".
BR112013015527A2 (pt) implante crestal e método para o seu processamento
FI20085409A0 (fi) Menetelmä ja laite viestien käsittelemiseksi
BRPI0923290A2 (pt) métodos para remover acrilamida em uma massa aquosa de fluido, e para remover acrilamida em um fluido aquoso de tratamento de poço, e, composição aquosa de fluido para tratamento de poço.
BR112013015453A2 (pt) composição não-espumante e método para o tratamento não-terapêutico das matérias queratínicas
EP2527671A4 (en) TORQUE COMPENSATION PROCEDURE FOR A FOUR-POINT CONTACT BALL BEARING AND CALCULATION DEVICE AND CALCULATION PROGRAM THEREFOR
EP2554709A4 (en) BEARING ELEMENT, BEARING, AND BEARING ELEMENT INSPECTION METHOD
BR112012005140A2 (pt) inibidores de hsl úteis no tratamento de diabetes
FR2954907B1 (fr) Composition cosmetique, procede de traitement cosmetique et kit
EP2410337A4 (en) PROCESS FOR BETA-GLUCAN MEASUREMENT AND BETA-GLUCAN BINDING PROTEIN FOR USE IN THIS METHOD
BR112014000219A2 (pt) dispositivo de ensaio para a detecção de uma enzima ativa em uma amostra, método de determinação de presença e dos níveis de uma enzima ativa em uma amostra, kit, dispositivo de ensaio, ou método de uso ou o uso do mesmo e uso
BRPI1014960A2 (pt) sistema para uso em uma aplicação de poço submarino, e método
BRPI0914933A2 (pt) Composições e métodos para níveis de aminoácido aumentados em plantas
EE201000069A (et) Meetod ja elektrolser desinfitseeriva vahendi saamiseks

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/04/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.